CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Bioxyne Limited Company Snapshot
Bioxyne Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other companies in this sector in AUSTRALIA : Amplia Therapeutics Ltd (2021 sales of 1.53 million Australian Dollars [US$1.11 million] ), Zelira Therapeutics Ltd (2.09 million Australian Dollars [US$1.52 million] of which 27% was USA), and Invion Limited (2.33 million Australian Dollars [US$1.69 million] of which 100% was Drug Development).

Sales Analysis. During the year ended June of 2021, sales at Bioxyne Limited were A$2.11 million (US$1.53 million). This is a decrease of 6.6% versus 2020, when the company's sales were A$2.26 million. The sales level in 2021 was fairly close to the level five years ago: in 2016, Bioxyne Limited had sales of A$1.92 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Bioxyne Limited
  Stock Performance Chart for Bioxyne Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (9/16/2021): .03
(Figures in Australian Dollars)
1 Week -20.0%   13 Weeks -12.5%  
4 Weeks 21.7%   52 Weeks 133.3%  
 
Bioxyne Limited Key Data:
  Ticker: BXN Country: Australia
  Exchanges: BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2021 Sales 2,110,377
(Year Ending Jan 2022).
Employees: 16
  Currency: Australian Dollars Market Cap: 17,924,071
  Fiscal Yr Ends: June Shares Outstanding: 640,145,398
  Share Type: Ordinary Closely Held Shares: 420,247,892
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.